Premium
No increased risk of psychosis from methylphenidate use in young patients
Publication year - 2019
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30481
Subject(s) - methylphenidate , psychosis , psychiatry , cohort , medicine , psychology , pediatrics , attention deficit hyperactivity disorder
A cohort study examining patients who were initiated to methylphenidate treatment between the ages of 12 and 30 has found no evidence of increased risk of psychosis in this group as a result of methylphenidate initiation. The study's findings contradict a prevalent view that methylphenidate increases the risk of psychotic events in young people and should be avoided in patients with a history of psychotic illness. Study results were published online June 17 in Lancet Psychiatry .